Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Share-based Compensation (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Share-based Compensation data on record, last reported at $401000.0 in Q4 2019.

  • For Q4 2019, Share-based Compensation rose 516.92% year-over-year to $401000.0; the TTM value through Dec 2019 reached $1.2 million, up 87.74%, while the annual FY2024 figure was $2.1 million, 23.89% up from the prior year.
  • Share-based Compensation reached $401000.0 in Q4 2019 per DMAC's latest filing, down from $451000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $451000.0 in Q3 2019 and bottomed at $65000.0 in Q4 2018.